Boehringer Ingelheim
pharma Ridgefield, CT · Private
Boehringer Ingelheim is a major global pharmaceutical manufacturer with significant US operations across multiple therapeutic areas including cardiovascular, respiratory, oncology, and metabolic treatments. The company maintains a diversified manufacturing footprint across nine known facilities in the US, supporting both pharmaceutical production and contract biopharmaceutical services.
Boehringer Ingelheim is a privately held, family-owned global pharmaceutical company that develops and manufactures prescription medicines for human health (including cardiovascular, respiratory, oncology, and metabolic therapies), animal health vaccines and parasiticides, and contract biopharmaceutical manufacturing services. It is headquartered in Ingelheim, Germany, with its US operations centered in Ridgefield, Connecticut.
Employees
54,500
Mfg Plants
5
All Facilities
9
Activity
3/10
Type
Private
Plant Locations (9 mapped)
0
Recent News
No news articles yet.
Manufacturing Plants (5)
Boehringer Ingelheim Fremont Biopharmaceuticals (BioXcellence)
Fremont, CA
BI's only US biopharmaceutical manufacturing site, established 2011 and expanded in 2018. Produces monoclonal antibodies and recombinant proteins via mammalian cell culture (2,000 L and 15,000 L scales). Operates as BioXcellence contract development and manufacturing organization (CDMO). 300,000 sq ft, 700+ employees.
Boehringer Ingelheim Animal Health – Athens R&D and Manufacturing
Athens, GA
BI's largest US animal health R&D site and third largest globally; also BI's largest pet vaccine production facility for the US and a key manufacturing site for poultry and wildlife vaccines. Expanded in 2024 with a $66M investment adding 63,000 sq ft administrative and 28,000 sq ft lab space. Located near USDA National Poultry Research Center and University of Georgia.
Boehringer Ingelheim Vetmedica – Sioux Center Manufacturing
Sioux Center, IA
Animal health manufacturing facility focused on swine vaccine production. Part of BI's US Animal Health manufacturing network.
Boehringer Ingelheim Animal Health – St. Joseph Manufacturing
Saint Joseph, MO
BI's largest US animal health manufacturing operation and formerly its global animal health manufacturing flagship; produces livestock and equine vaccines and biologicals. 700,000+ sq ft campus with manufacturing, warehouse, and R&D functions. ~800 employees as of 2026; underwent workforce optimization in early 2026 but remains active.
Boehringer Ingelheim Animal Health Puerto Rico – Barceloneta Manufacturing
Barceloneta, PR
Manufactures pet parasiticides including HEARTGARD Plus (ivermectin/pyrantel) and NexGard (afoxolaner). Facility has operated for 48+ years; expanded in 2019 with a ~$50M investment to add NexGard manufacturing capacity and up to 105 new jobs. ~300 employees.
Other Facilities (4)
Boehringer Ingelheim US Headquarters
Ridgefield, CT · hq
US corporate HQ on a 294-acre campus straddling the Ridgefield/Danbury border; houses the Human Pharmaceuticals business hub, the Innovation Unit R&D center, and a pilot plant that produces active pharmaceutical ingredients for early-stage drug development. Home to more than 2,000 employees.
Boehringer Ingelheim Animal Health USA – US Animal Health HQ
Duluth, GA · hq
Headquarters of Boehringer Ingelheim's US Animal Health division (formerly Merial). Administrative and commercial leadership for the US animal health business.
Boehringer Ingelheim Animal Health – Ames R&D (ISU Research Park)
Ames, IA · r&d
52,000 sq ft, $22M research facility opened 2016 at Iowa State University Research Park. Conducts animal health R&D across swine, cattle, equine, canine, and feline species. Up to 100 scientists on site; benefits from proximity to Iowa State University, USDA National Animal Disease Center, and National Veterinary Services Laboratories.
Boehringer Ingelheim Animal Health – North Brunswick
North Brunswick, NJ · r&d
Animal health facility located at or near the New Jersey Bioscience Center on Route 1 in North Brunswick, NJ. One of BI Animal Health's seven US sites; involved in pharmaceutical research and development for the animal health portfolio.